SCHEMBL29856265

SCHEMBL29856265

Cn1c(C2CC2)c(C(=O)c2cc(Cl)c(O)c(Cl)c2)c2cccnc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 4/20 0.47
SLC22A6 Q4U2R8 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
COMT P21964 2/20 0.37
ELANE P08246 1/20 0.37
EGFR P00533 1/20 0.37
SRC P12931 1/20 0.37
TNKS O95271 1/20 0.37
RORC P51449 3/20 0.37
ALOX12 P18054 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALOX15B O15296 1/20 0.36
NR1I2 O75469 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29856282 0.80 SLC22A12 (0.48) SLC22A12SLC22A6ABCG2ELANEEGFR
SCHEMBL29856218 0.78 SLC22A12 (0.44) SLC22A12ELANE
SCHEMBL17846559 0.74 ELANE (0.41) ELANEEGFRSRCKDM4EFEN1
SCHEMBL29856150 0.74 SLC22A12 (0.42) SLC22A12ELANE
SCHEMBL29856402 0.72 SLC22A12 (0.31) SLC22A12
SCHEMBL29856491 0.72 SLC22A12 (0.38) SLC22A12RORCCYP3A4
SCHEMBL29856251 0.70 ELANE (0.41) SLC22A12ELANEMAPTCYP2C9
SCHEMBL14739634 0.66 PTGDR2 (0.39) TNKSKDM4EALDH1A1LMNACYP3A4
SCHEMBL14739637 0.66 PTGDR2 (0.39) TNKSKDM4EALDH1A1LMNACYP3A4
SCHEMBL29856136 0.66 SLC22A12 (0.47) SLC22A12SLC22A6ABCG2ELANEEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022169974-A1 INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed